Regulation of TNFRSF and innate immune signalling complexes by TRAFs and cIAPs

Cell Death and Differentiation

Volumn 17, Issue 1, 2010, Pages 35-45

  Silke, J ^a   Brink, R ^b  

^a LA TROBE UNIVERSITY   (Australia)

^b GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

Apoptosis; cIAPs; kinases; NIK; RIPK1; TNF

Indexed keywords

I KAPPA B KINASE GAMMA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INHIBITOR OF APOPTOSIS PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE KINASE; PHOSPHOTRANSFERASE; RIPK1 PROTEIN; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 3; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG; DNA BINDING PROTEIN; NF KAPPA B KINASE; NF-KAPPA B KINASE; PROTEIN SERINE THREONINE KINASE; RECEPTOR INTERACTING PROTEIN SERINE THREONINE KINASE; UBIQUITIN PROTEIN LIGASE;

B LYMPHOCYTE; CELL SURVIVAL; ENZYME ACTIVATION; INNATE IMMUNITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEPLETION; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; APOPTOSIS; METABOLISM;

INTRACISTERNAL A-PARTICLES;

APOPTOSIS; DNA-BINDING PROTEINS; IMMUNITY, INNATE; INHIBITOR OF APOPTOSIS PROTEINS; NF-KAPPA B; PROTEIN-SERINE-THREONINE KINASES; RECEPTOR-INTERACTING PROTEIN SERINE-THREONINE KINASES; RECEPTORS, TUMOR NECROSIS FACTOR; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR RECEPTOR-ASSOCIATED PEPTIDES AND PROTEINS; UBIQUITIN-PROTEIN LIGASES;

EID: 77449147556     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/cdd.2009.114     Document Type: Review

References (105)

1. Rothe M, Wong SC, Henzel WJ, Goeddel DV. A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor. Cell 1994; 78: 681-692. (Pubitemid 24268590)
2. Naito A, Yoshida H, Nishioka E, Satoh M, Azuma S, Yamamoto T et al. TRAF6-deficient mice display hypohidrotic ectodermal dysplasia. Proc Natl Acad Sci USA 2002; 99: 8766-8771. (Pubitemid 34693634)
3. Tsitsikov EN, Laouini D, Dunn IF, Sannikova TY, Davidson L, Alt FW et al. TRAF1 is a negative regulator of TNF signaling. Enhanced TNF signaling in TRAF1-deficient mice. Immunity 2001; 15: 647-657. (Pubitemid 33016449)
4. Wu H, Arron JR. TRAF6, a molecular bridge spanning adaptive immunity, innate immunity and osteoimmunology. Bioessays 2003; 25: 1096-1105. (Pubitemid 37411769)
5. Rothe M, Pan MG, Henzel WJ, Ayres TM, Goeddel DV. The TNF-R2-TRAF signaling complex contains two novel proteins related to baculoviral-inhibitor of apoptosis proteins. Cell 1995; 83: 1243-1252. (Pubitemid 26007814)
6. Wertz IE, O'Rourke KM, Zhou H, Eby M, Aravind L, Seshagiri S et al. De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling. Nature 2004; 430: 694-699. (Pubitemid 39061687)
7. Park SM, Yoon JB, Lee TH. Receptor interacting protein is ubiquitinated by cellular inhibitor of apoptosis proteins (c-IAP1 and c-IAP2) in vitro. FEBS Lett 2004; 566: 151-156. (Pubitemid 38625950)
8. Christensen DE, Brzovic PS, Klevit RE. E2-BRCA1 RING interactions dictate synthesis of mono- or specific polyubiquitin chain linkages. Nat Struct Mol Biol 2007; 14: 941-948. (Pubitemid 47525175)
9. Blankenship JW, Varfolomeev E, Goncharov T, Fedorova AV, Kirkpatrick DS, Izrael- Tomasevic A et al. Ubiquitin binding modulates IAP antagonist-stimulated proteasomal degradation of c-IAP1 and c-IAP2(1). Biochem J 2009; 417: 149-160.
10. Bertrand MJ, Milutinovic S, Dickson KM, Ho WC, Boudreault A, Durkin J et al. cIAP1 and cIAP2 facilitate cancer cell survival by functioning as E3 ligases that promote RIP1 ubiquitination. Mol Cell 2008; 30: 689-700. (Pubitemid 351818251)
11. Vince JE, Wong WW, Khan N, Feltham R, Chau D, Ahmed AU et al. IAP antagonists target cIAP1 to induce TNFalpha-dependent apoptosis. Cell 2007; 131: 682-693. (Pubitemid 350103599)
12. Vince JE, Chau D, Callus B, Wong WW, Hawkins CJ, Schneider P et al. TWEAK-FN14 signaling induces lysosomal degradation of a cIAP1-TRAF2 complex to sensitize tumor cells to TNFalpha. J Cell Biol 2008; 182: 171-184. (Pubitemid 352008630)
13. Vaux DL, Silke J. IAPs, RINGs and ubiquitylation. Nat Rev Mol Cell Biol 2005; 6: 287-297.
14. Varfolomeev E, Wayson SM, Dixit VM, Fairbrother WJ, Vucic D. The inhibitor of apoptosis protein fusion c-IAP2.MALT1 stimulates NF-κB activation independently of TRAF1 AND TRAF2. J Biol Chem 2006; 281: 29022-29029. (Pubitemid 44507046)
15. Wiley SR, Cassiano L, Lofton T, Davis-Smith T, Winkles JA, Lindner V et al. A novel TNF receptor family member binds TWEAK and is implicated in angiogenesis. Immunity 2001; 15: 837-846. (Pubitemid 34008510)
16. Basak S, Hoffmann A. Crosstalk via the NF-kappaB signaling system. Cytokine Growth Factor Rev 2008; 19: 187-197.
17. Xie P, Kraus ZJ, Stunz LL, Bishop GA. Roles of TRAF molecules in B lymphocyte function. Cytokine Growth Factor Rev 2008; 19: 199-207.
18. Schneider P. Signaling by TNF and related ligands. Oxford Monographs on Medical Genetics 2004; 49: 340-358.
19. Chen LF, Greene WC. Shaping the nuclear action of NF-kappaB. Nat Rev Mol Cell Biol 2004; 5: 392-401.
20. Mordmüller B, Krappmann D, Esen M, Wegener E, Scheidereit C. Lymphotoxin and lipopolysaccharide induce NF-kappaB-p52 generation by a co-translational mechanism. EMBO Rep 2003; 4: 82-87.
21. Coope HJ, Atkinson PG, Huhse B, Belich M, Janzen J, Holman MJ et al. CD40 regulates the processing of NF-kappaB2 p100 to p52. EMBO J 2002; 21: 5375-5385. (Pubitemid 35231017)
22. Claudio E, Brown K, Park S, Wang H, Siebenlist U. BAFF-induced NEMO-independent processing of NF-kappa B2 in maturing B cells. Nat Immunol 2002; 3: 958-965. (Pubitemid 35154010)
23. Dejardin E, Droin NM, Delhase M, Haas E, Cao Y, Makris C et al. The lymphotoxin-b receptor induces different patterns of gene expression via two NF-κB pathways. Immunity 2002; 17: 525-535. (Pubitemid 35223540)
24. Basak S, Kim H, Kearns JD, Tergaonkar V, O'Dea E, Werner SL et al. A fourth IkappaB protein within the NF-kappaB signaling module. Cell 2007; 128: 369-381. (Pubitemid 46123518)
25. Hoffmann A, Baltimore D. Circuitry of nuclear factor kappaB signaling. Immunol Rev 2006; 210: 171-186.
26. Phelps CB, Sengchanthalangsy LL, Huxford T, Ghosh G. Mechanism of I kappa B alpha binding to NF-kappa B dimers. J Biol Chem 2000; 275: 29840-29846. (Pubitemid 32043869)
27. Bates PW, Miyamoto S. Expanded nuclear roles for IkappaBs. Sci STKE 2004; 2004: pe48.
28. Wu CJ, Conze DB, Li T, Srinivasula SM, Ashwell JD. Sensing of Lys 63-linked polyubiquitination by NEMO is a key event in NF-kappaB activation [corrected]. Nat Cell Biol 2006; 8: 398-406.
29. Ea CK, Deng L, Xia ZP, Pineda G, Chen ZJ. Activation of IKK by TNFalpha requires sitespecific ubiquitination of RIP1 and polyubiquitin binding by NEMO. Mol Cell 2006; 22: 245-257.
30. Lo YC, Lin SC, Rospigliosi CC, Conze DB, Wu CJ, Ashwell JD et al. Structural basis for recognition of diubiquitins by NEMO. Mol Cell 2009; 33: 602-615.
31. Sato S, Sanjo H, Takeda K, Ninomiya-Tsuji J, Yamamoto M, Kawai T et al. Essential function for the kinase TAK1 in innate and adaptive immune responses. Nat Immunol 2005; 6: 1087-1095. (Pubitemid 41541786)
32. Lee TH, Shank J, Cusson N, Kelliher MA. The kinase activity of Rip1 is not required for tumor necrosis factor-alpha-induced IkappaB kinase or p38 MAP kinase activation or for the ubiquitination of Rip1 by Traf2. J Biol Chem 2004; 279: 33185-33191. (Pubitemid 39062963)
33. Yamamoto M, Okamoto T, Takeda K, Sato S, Sanjo H, Uematsu S et al. Key function for the Ubc13 E2 ubiquitin-conjugating enzyme in immune receptor signaling. Nat Immunol 2006; 7: 962-970. (Pubitemid 44263910)
34. Mahoney DJ, Cheung HH, Mrad RL, Plenchette S, Simard C, Enwere E et al. Both cIAP1 and cIAP2 regulate TNFalpha-mediated NF-kappaB activation. Proc Natl Acad Sci USA 2008; 105: 11778-11783.
35. Varfolomeev E, Goncharov T, Fedorova AV, Dynek JN, Zobel K, Deshayes K et al. c-IAP1 and c-IAP2 are critical mediators of tumor necrosis factor alpha (TNFalpha)-induced NFkappaB activation. J Biol Chem 2008; 283: 24295-24299.
36. Newton K, Matsumoto ML, Wertz IE, Kirkpatrick DS, Lill JR, Tan J et al. Ubiquitin chain editing revealed by polyubiquitin linkage-specific antibodies. Cell 2008; 134: 668-678.
37. Tang ED, Wang CY, Xiong Y, Guan KL. A role for NF-kappaB essential modifier/IkappaB kinase-gamma (NEMO/IKKgamma) ubiquitination in the activation of the IkappaB kinase complex by tumor necrosis factor-alpha. J Biol Chem 2003; 278: 37297-37305. (Pubitemid 37175246)
38. Bishop GA. The multifaceted roles of TRAFs in the regulation of B-cell function. Nat Rev Immunol 2004; 4: 775-786. (Pubitemid 39336294)
39. Ye H, Park YC, Kreishman M, Kieff E, Wu H. The structural basis for the recognition of diverse receptor sequences by TRAF2. Mol Cell 1999; 4: 321-330. (Pubitemid 29499785)
40. Ni CZ, Oganesyan G, Welsh K, Zhu X, Reed JC, Satterthwait AC et al. Key molecular contacts promote recognition of the BAFF receptor by TNF receptor-associated factor 3: implications for intracellular signaling regulation. J Immunol 2004; 173: 7394-7400. (Pubitemid 39628178)
41. Park YC, Ye H, Hsia C, Segal D, Rich RL, Liou HC et al. A novel mechanism of TRAF signaling revealed by structural and functional analyses of the TRADD-TRAF2 interaction. Cell 2000; 101: 777-787.
42. Hauer J, Püschner S, Ramakrishnan P, Simon U, Bongers M, Federle C et al. TNF receptor (TNFR)-associated factor (TRAF) 3 serves as an inhibitor of TRAF2/5-mediated activation of the noncanonical NF-kappaB pathway by TRAF-binding TNFRs. Proc Natl Acad Sci USA 2005; 102: 2874-2879. (Pubitemid 40299884)
43. Hu HM, O'Rourke K, Boguski MS, Dixit VM. A novel RING finger protein interacts with the cytoplasmic domain of CD40. J Biol Chem 1994; 269: 30069-30072. (Pubitemid 24376462)
44. Xu LG, Shu HB. TNFR-associated factor-3 is associated with BAFF-R and negatively regulates BAFF-R-mediated NF-kappa B activation and IL-10 production. J Immunol 2002; 169: 6883-6889.
45. Duckett CS, Thompson CB. CD30-dependent degradation of TRAF2 - implications for negative regulation of TRAF signaling and the control of cell survival. Genes Dev 1997; 11: 2810-2821. (Pubitemid 27481682)
46. Csomos RA, Wright CW, Galbán S, Oetjen KA, Duckett CS. Two distinct signalling cascades target the NF-kappaB regulatory factor c-IAP1 for degradation. Biochem J 2009; 420: 83-91.
47. Li X, Yang Y, Ashwell JD. TNF-RII and c-IAP1 mediate ubiquitination and degradation of TRAF2. Nature 2002; 416: 345-347.
48. Brown KD, Hostager BS, Bishop GA. Differential signaling and tumor necrosis factor receptor-associated factor (TRAF) degradation mediated by CD40 and the Epstein-Barr virus oncoprotein latent membrane protein 1 (LMP1). J Exp Med 2001; 193: 943-954. (Pubitemid 32525867)
49. Liao G, Zhang M, Harhaj EW, Sun SC. Regulation of the NF-kappaB-inducing kinase by tumor necrosis factor receptor-associated factor 3-induced degradation. J Biol Chem 2004; 279: 26243-26250. (Pubitemid 38798772)
50. Malinin NL, Boldin MP, Kovalenko AV, Wallach D. MAP3K-related kinase involved in NF-κB induction by TNF, CD 95 and IL-1. Nature 1997; 385: 540-544. (Pubitemid 27074673)
51. Vallabhapurapu S, Matsuzawa A, Zhang W, Tseng PH, Keats JJ, Wang H et al. Nonredundant and complementary functions of TRAF2 and TRAF3 in a ubiquitination cascade that activates NIK-dependent alternative NF-kappaB signaling. Nat Immunol 2008; 9: 1364-1370.
52. He JQ, Zarnegar B, Oganesyan G, Saha SK, Yamazaki S, Doyle SE et al. Rescue of TRAF3-null mice by p100 NF-κB deficiency. J Exp Med 2006; 203: 2413-2418. (Pubitemid 44664610)
53. Ishikawa H, Carrasco D, Claudio E, Ryseck RP, Bravo R. Gastric hyperplasia and increased proliferative responses of lymphocytes in mice lacking the COOH-terminal ankyrin domain of NF-kappaB2. J Exp Med 1997; 186: 999-1014. (Pubitemid 27441145)
54. Zarnegar B, Yamazaki S, He JQ, Cheng G. Control of canonical NF-kappaB activation through the NIK-IKK complex pathway. Proc Natl Acad Sci USA 2008; 105: 3503-3508. (Pubitemid 351723582)
55. Yeh WC, Shahinian A, Speiser D, Kraunus J, Billia F, Wakeham A et al. Early lethality, functional NF-kappaB activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice. Immunity 1997; 7: 715-725. (Pubitemid 28156638)
56. Nguyen LT, Duncan GS, Mirtsos C, Ng M, Speiser DE, Shahinian A et al. TRAF2 deficiency results in hyperactivity of certain TNFR1 signals and impairment of CD40- mediated responses. Immunity 1999; 11: 379-389. (Pubitemid 29463246)
57. Lee SY, Reichlin A, Santana A, Sokol KA, Nussenzweig MC, Choi Y. Traf2 is essential for JNK but not NF-kappa-B activation and regulates lymphocyte proliferation and survival. Immunity 1997; 7: 703-713. (Pubitemid 28156637)
58. Grech AP, Amesbury M, Chan T, Gardam S, Basten A, Brink R. TRAF2 differentially regulates the canonical and noncanonical pathways of NF-κB activation in mature B cells. Immunity 2004; 21: 629-642. (Pubitemid 39487887)
59. Ramakrishnan P, Wang W, Wallach D. Receptor-specific signaling for both the alternative and the canonical NF-kappaB activation pathways by NF-kappaB-inducing kinase. Immunity 2004; 21: 477-489. (Pubitemid 39370504)
60. Varfolomeev E, Blankenship JW, Wayson SM, Fedorova AV, Kayagaki N, Garg P et al. IAP antagonists induce autoubiquitination of c-IAPs, NF-kappaB activation, and TNFalpha-dependent apoptosis. Cell 2007; 131: 669-681. (Pubitemid 350087204)
61. Zarnegar BJ, Wang Y, Mahoney DJ, Dempsey PW, Cheung HH, He J et al. Noncanonical NF-kappaB activation requires coordinated assembly of a regulatory complex of the adaptors cIAP1, cIAP2, TRAF2 and TRAF3 and the kinase NIK. Nat Immunol 2008; 9: 1371-1378.
62. Keats JJ, Fonseca R, Chesi M, Schop R, Baker A, Chng WJ et al. Promiscuous mutations activate the noncanonical NF-kappaB pathway in multiple myeloma. Cancer Cell 2007; 12: 131-144. (Pubitemid 47208626)
63. Annunziata CM, Davis RE, Demchenko Y, Bellamy W, Gabrea A, Zhan F et al. Frequent engagement of the classical and alternative NF-kappaB pathways by diverse genetic abnormalities in multiple myeloma. Cancer Cell 2007; 12: 115-130. (Pubitemid 47199123)
64. Hostager BS, Haxhinasto SA, Rowland SL, Bishop GA. Tumor necrosis factor receptorassociated factor 2 (TRAF2)-deficient B lymphocytes reveal novel roles for TRAF2 in CD40 signaling. J Biol Chem 2003; 278: 45382-45390. (Pubitemid 37432675)
65. Pullen SS, Dang TT, Crute JJ, Kehry MR. CD40 signaling through tumor necrosis factor receptor-associated factors (TRAFs). Binding site specificity and activation of downstream pathways by distinct TRAFs. J Biol Chem 1999; 274: 14246-14254.
66. Zhao Y, Conze DB, Hanover JA, Ashwell JD. Tumor necrosis factor receptor 2 signaling induces selective c-IAP1-dependent ASK1 ubiquitination and terminates mitogenactivated protein kinase signaling. J Biol Chem 2007; 282: 7777-7782. (Pubitemid 47093598)
67. Kuranaga E, Kanuka H, Igaki T, Sawamoto K, Ichijo H, Okano H et al. Reaper-mediated inhibition of DIAP1-induced DTRAF1 degradation results in activation of JNK in Drosophila. Nat Cell Biol 2002; 4: 705-710. (Pubitemid 34993707)
68. Grell M, Douni E, Wajant H, Löhden M, Clauss M, Maxeiner B et al. The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor. Cell 1995; 83: 793-802.
69. Huang DC, Hahne M, Schroeter M, Frei K, Fontana A, Villunger A et al. Activation of Fas by FasL induces apoptosis by a mechanism that cannot be blocked by Bcl-2 or Bcl-xL. Proc Natl Acad Sci 1999; 96: 14871-14876. (Pubitemid 30019732)
70. Holler N, Tardivel A, Kovacsovics-Bankowski M, Hertig S, Gaide O, Martinon F et al. Two adjacent trimeric Fas ligands are required for Fas signaling and formation of a death-inducing signaling complex. Mol Cell Biol 2003; 23: 1428-1440. (Pubitemid 36177050)
71. Baccam M, Bishop GA. Membrane-bound CD154, but not CD40-specific antibody, mediates NF-kappaB-independent IL-6 production in B cells. Eur J Immunol 1999; 29: 3855-3866.
72. Micheau O, Tschopp J. Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell 2003; 114: 181-190. (Pubitemid 36936912)
73. Habelhah H, Takahashi S, Cho SG, Kadoya T, Watanabe T, Ronai Z. Ubiquitination and translocation of TRAF2 is required for activation of JNK but not of p38 or NF-kappaB. EMBO J 2004; 23: 322-332. (Pubitemid 38294497)
74. Wu CJ, Conze DB, Li X, Ying SX, Hanover JA, Ashwell JD. TNF-alpha induced c-IAP1/ TRAF2 complex translocation to a Ubc6-containing compartment and TRAF2 ubiquitination. EMBO J 2005; 24: 1886-1898. (Pubitemid 40769507)
75. Matsuzawa A, Tseng PH, Vallabhapurapu S, Luo JL, Zhang W, Wang H et al. Essential cytoplasmic translocation of a cytokine receptor-assembled signaling complex. Science 2008; 321: 663-668.
76. UrbéS. Ubiquitin and endocytic protein sorting. Essays Biochem 2005; 41: 81-98. (Pubitemid 41500972)
77. Vercammen D, Vandenabeele P, Declercq W, Van de Craen M, Grooten J, Fiers W. Cytotoxicity in L929 murine fibrosarcoma cells after triggering of transfected human p75 tumour necrosis factor (TNF) receptor is mediated by endogenous murine TNF. Cytokine 1995; 7: 463-470.
78. Grell M, Zimmermann G, Gottfried E, Chen CM, Grunwald U, Huang DC et al. Induction of cell death by tumour necrosis factor (TNF) receptor 2, CD40 and CD30: a role for TNF-R1 activation by endogenous membrane-anchored TNF. EMBO J 1999; 18: 3034-3043. (Pubitemid 29255612)
79. Fotin-Mleczek M, Henkler F, Samel D, Reichwein M, Hausser A, Parmryd I et al. Apoptotic crosstalk of TNF receptors: TNF-R2-induces depletion of TRAF2 and IAP proteins and accelerates TNF-R1-dependent activation of caspase-8. J Cell Sci 2002; 115: 2757-2770. (Pubitemid 34846516)
80. Schneider P, Schwenzer R, Haas E, Muhlenbeck F, Schubert G, Scheurich P et al. TWEAK can induce cell death via endogenous TNF and TNF receptor 1. Eur J Immunol 1999; 29: 1785-1792. (Pubitemid 29265533)
81. Vince JE, Silke J. TWEAK shall inherit the earth. Cell Death Differ 2006; 13: 1842-1844. (Pubitemid 44542397)
82. Schiemann B, Gommerman JL, Vora K, Cachero TG, Shulga-Morskaya S, Dobles M et al. An essential role for BAFF in the normal development of B cells through a BCMAindependent pathway. Science 2001; 293: 2111-2114. (Pubitemid 32848063)
83. Sasaki Y, Casola S, Kutok JL, Rajewsky K, Schmidt-Supprian M. TNF family member B cell-activating factor (BAFF) receptor-dependent and -independent roles for BAFF in B cell physiology. J Immunol 2004; 173: 2245-2252. (Pubitemid 39063079)
84. Benson MJ, Dillon SR, Castigli E, Geha RS, Xu S, Lam KP et al. Cutting edge: the dependence of plasma cells and independence of memory B cells on BAFF and APRIL. J Immunol 2008; 180: 3655-3659.
85. Miosge LA, Blasioli J, Blery M, Goodnow CC. Analysis of an ethylnitrosourea-generated mouse mutation defines a cell intrinsic role of nuclear factor kappaB2 in regulating circulating B cell numbers. J Exp Med 2002; 196: 1113-1119. (Pubitemid 35231770)
86. Yamada T, Mitani T, Yorita K, Uchida D, Matsushima A, Iwamasa K et al. Abnormal immune function of hemopoietic cells from alymphoplasia (aly) mice, a natural strain with mutant NF-kappa B-inducing kinase. J Immunol 2000; 165: 804-812. (Pubitemid 30484747)
87. Gardam S, Sierro F, Basten A, Mackay F, Brink R. TRAF2 and TRAF3 signal adapters act cooperatively to control the maturation and survival signals delivered to B cells by the BAFF receptor. Immunity 2008; 28: 391-401.
88. Xie P, Stunz LL, Larison KD, Yang B, Bishop GA. Tumor necrosis factor receptorassociated factor 3 is a critical regulator of B cell homeostasis in secondary lymphoid organs. Immunity 2007; 27: 253-267. (Pubitemid 47284931)
89. Ahmed AU, Moulin M, Coumailleau F, Wong WW, Miasari M, Carter H et al. CARP2 deficiency does not alter induction of NF-kappaB by TNFalpha. Curr Biol 2009; 19: R15-R17; author reply R17-9.
90. Liao W, Xiao Q, Tchikov V, Fujita K, Yang W, Wincovitch S et al. CARP-2 is an endosome-associated ubiquitin ligase for RIP and regulates TNF-induced NF-kappaB activation. Curr Biol 2008; 18: 641-649.
91. Shembade N, Parvatiyar K, Harhaj NS, Harhaj EW. The ubiquitin-editing enzyme A20 requires RNF11 to downregulate NF-kappaB signalling. EMBO J 2009; 28: 513-522.
92. Tokunaga F, Sakata SI, Saeki Y, Satomi Y, Kirisako T, Kamei K et al. Involvement of linear polyubiquitylation of NEMO in NF-kappaB activation. Nat Cell Biol 2009; 11: 123-132.
93. Kirisako T, Kamei K, Murata S, Kato M, Fukumoto H, Kanie M et al. A ubiquitin ligase complex assembles linear polyubiquitin chains. EMBO J 2006; 25: 4877-4887. (Pubitemid 44607032)
94. Lemaitre B, Hoffmann J. The host defense of Drosophila melanogaster. Annu Rev Immunol 2007; 25: 697-743. (Pubitemid 46697922)
95. Leulier F, Lhocine N, Lemaitre B, Meier P. The Drosophila inhibitor of apoptosis protein DIAP2 functions in innate immunity and is essential to resist Gram-negative bacterial infection. Mol Cell Biol 2006; 26: 7821-7831. (Pubitemid 44630984)
96. Bertrand MJ, Doiron K, LabbéK, Korneluk RG, Barker PA, Saleh M. Cellular inhibitors of apoptosis cIAP1 and cIAP2 are required for innate immunity signaling by the pattern recognition receptors NOD1 and NOD2. Immunity 2009; 30: 789-801.
97. Meylan E, Burns K, Hofmann K, Blancheteau V, Martinon F, Kelliher M et al. RIP1 is an essential mediator of Toll-like receptor 3-induced NF-kappa B activation. Nat Immunol 2004; 5: 503-507. (Pubitemid 38660462)
98. Cusson-Hermance N, Khurana S, Lee TH, Fitzgerald KA, Kelliher MA. Rip1 mediates the Trif-dependent Toll-like receptor 3- and 4-induced NF-{kappa}B activation but does not contribute to interferon regulatory factor 3 activation. J Biol Chem 2005; 280: 36560-36566. (Pubitemid 41587731)
99. Ermolaeva MA, Michallet MC, Papadopoulou N, Utermöhlen O, Kranidioti K, Kollias G et al. Function of TRADD in tumor necrosis factor receptor 1 signaling and in TRIF-dependent inflammatory responses. Nat Immunol 2008; 9: 1037-1046.
100. Pobezinskaya YL, Kim YS, Choksi S, Morgan MJ, Li T, Liu C et al. The function of TRADD in signaling through tumor necrosis factor receptor 1 and TRIF-dependent Toll-like receptors. Nat Immunol 2008; 9: 1047-1054.
101. Hitotsumatsu O, Ahmad RC, Tavares R, Wang M, Philpott D, Turer EE et al. The ubiquitin-editing enzyme A20 restricts nucleotide-binding oligomerization domain containing 2-triggered signals. Immunity 2008; 28: 381-390. (Pubitemid 351343859)
102. Kaiser WJ, Upton JW, Mocarski ES. Receptor-interacting protein homotypic interaction motif-dependent control of NF-kappaB activation via the DNA-dependent activator of IFN regulatory factors. J Immunol 2008; 181: 6427-6434.
103. Michallet MC, Meylan E, Ermolaeva MA, Vazquez J, Rebsamen M, Curran J et al. TRADD protein is an essential component of the RIG-like helicase antiviral pathway. Immunity 2008; 28: 651-661.
104. Conze DB, Albert L, Ferrick DA, Goeddel DV, Yeh WC, Mak T et al. Posttranscriptional downregulation of c-IAP2 by the ubiquitin protein ligase c-IAP1 in vivo. Mol Cell Biol 2005; 25: 3348-3356. (Pubitemid 40464334)
105. Conte D, Holcik M, Lefebvre CA, Lacasse E, Picketts DJ, Wright KE et al. Inhibitor of apoptosis protein cIAP2 is essential for lipopolysaccharide-induced macrophage survival. Mol Cell Biol 2006; 26: 699-708. (Pubitemid 43090921)